A group of buyers singed a Cooperation Framework Agreement to acquire a 36.7% stake in Lifecome Biochemistry Co.,Ltd. from HOP LIK INVESTMENT COMPANY LIMITED, Fujie Investment Co., Ltd., and Beijing Kangmin Consulting Management Center (Limited Partnership) for approximately CNY 660 million.

Hangzhou Ciyin Investment Partnership (Limited Partnership), Shangrao Changxin No. 2 Enterprise Management Center (Limited Partnership), Hangzhou Yirui Investment Partnership (Limited Partnership), and Xiao Han singed a Cooperation Framework Agreement to acquire a 36.7% stake in Lifecome Biochemistry Co.,Ltd. (SZSE:002868) from HOP LIK (ASIA) INVESTMENT COMPANY LIMITED, Fujie (Pingtan) Investment Co., Ltd., and Beijing Kangmin Consulting Management Center (Limited Partnership) for approximately CNY 660 million on July 31, 2022. Under the terms, CNY 11.58 per share will be paid.

Post completion, Hangzhou Ciyin Investment, Shangrao Changxin No. 2 Enterprise and Hangzhou Yirui Investment will each hold 10% stake and Xiao Han will hold 6.73% stake whereas HOP LIK (ASIA) INVESTMENT will retain 2% stake. The transaction needs to be reviewed and approved at the general meeting of Lifecome BiochemicalÆs shareholders.